EST 0469B-comparison of high- and low-dose cyclophosphamide in human lung cancer

A controlled trial of high‐intermittent vs low‐chronic dose cyclophosphamide in human lung cancer failed to show the benefits reported in noncontrolled trials. There were no differences in toxicity observed.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medical and pediatric oncology 1978, Vol.5 (1), p.231-240
Hauptverfasser:	Hall, Thomas C., Pocock, Stuart, Brodovsky, Harvey, Horton, John, Shnider, Bruce I., Colsky, Jacob, Oberfield, Richard A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Clinical Trials as Topic cyclophosphamide Cyclophosphamide - administration & dosage Cyclophosphamide - adverse effects Cytoxan Drug Administration Schedule Female Hematopoiesis - drug effects Humans lung cancer Lung Neoplasms - drug therapy Male Middle Aged Time Factors Vomiting - chemically induced
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!